Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Overexpression of p53 in the endometrial gland in postmenopausal women.

Koi C, Hachisuga T, Murakami M, Kurita T, Nguyen TT, Shimajiri S, Fujino Y.

Menopause. 2015 Jan;22(1):104-7. doi: 10.1097/GME.0000000000000265.

PMID:
24893067
2.

Expression of p53 in endometrial polyps with special reference to the p53 signature.

Sho T, Hachisuga T, Kawagoe T, Urabe R, Kurita T, Kagami S, Shimajiri S, Fujino Y.

Histol Histopathol. 2016 Jul;31(7):751-8. doi: 10.14670/HH-11-713. Epub 2016 Jan 4.

PMID:
26727623
3.

Expression of p53, Ki-67, and CD31 proteins in endometrial polyps of postmenopausal women treated with tamoxifen.

Miranda SP, Traiman P, Cândido EB, Lages EL, Freitas GF, Lamaita RM, Vidigal PV, da Silva Filho AL.

Int J Gynecol Cancer. 2010 Dec;20(9):1525-30. doi: 10.1111/IGC.0b013e3181f7b33b.

PMID:
21119367
4.
5.

Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.

Zheng W, Liang SX, Yu H, Rutherford T, Chambers SK, Schwartz PE.

Int J Surg Pathol. 2004 Jul;12(3):207-23.

PMID:
15306933
6.
7.

Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.

Giordano G, Gnetti L, Merisio C, Melpignano M.

Maturitas. 2007 Feb 20;56(2):190-7. Epub 2006 Sep 11.

PMID:
16963204
9.

Expression of steroid receptors, Ki-67, and epidermal growth factor receptor in tamoxifen-treated endometrium.

Hachisuga T, Hideshima T, Kawarabayashi T, Eguchi F, Emoto M, Shirakusa T.

Int J Gynecol Pathol. 1999 Oct;18(4):297-303.

PMID:
10542936
11.

Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps.

Inceboz US, Nese N, Uyar Y, Ozcakir HT, Kurtul O, Baytur YB, Kandiloglu AR, Caglar H, Fraser IS.

Gynecol Obstet Invest. 2006;61(1):24-8. Epub 2005 Sep 2.

PMID:
16141722
12.

Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.

Dahmoun M, Odmark IS, Risberg B, Karlsson MG, Pavlenko T, Bäckström T.

Maturitas. 2004 Oct 15;49(2):114-23.

PMID:
15474755
13.

Expression of p53 protein in the endometrial polyp in postmenopausal women.

Neto LC, Soares JM Jr, Giusa-Chiferi MG, Gonçalves WJ, Baracat EC.

Eur J Gynaecol Oncol. 2013;34(6):509-12.

PMID:
24601040
14.

Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps?

Antunes A Jr, Andrade LA, Pinto GA, Leão R, Pinto-Neto AM, Costa-Paiva L.

Anal Quant Cytopathol Histpathol. 2012 Oct;34(5):264-72.

PMID:
23301386
15.

The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.

Mourits MJ, Ten Hoor KA, van der Zee AG, Willemse PH, de Vries EG, Hollema H.

J Clin Pathol. 2002 Jul;55(7):514-9.

17.

Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium.

Mourits MJ, Hollema H, De Vries EG, Ten Hoor KA, Willemse PH, Van Der Zee AG.

Hum Pathol. 2002 Mar;33(3):341-6.

PMID:
11979376
18.

Differential expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.

de Carvalho S, Campaner AB, Lima SM, Silva MA, Ribeiro PA.

Anal Quant Cytol Histol. 2011 Apr;33(2):61-7.

PMID:
21980607
20.

Supplemental Content

Support Center